The delay in Sun Pharma's launch of Leqselvi in the US was caused by a patent infringement case, which was later settled in a ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

LEQSELVI has shown rapid results in clinical trials, with one-third of patients regaining nearly full scalp hair by Week 24.

Round or oval patches of hair loss on the scalp, face, or body; Tingling, itching, or burning in the affected areas, either before or after hair loss; Nail changes, including ridges or pitting (dents) ...

How severe it is depends on the percentage of the scalp with hair loss. Mild alopecia areata ranges from 0% to 20%, moderate is from 21% to 49%, and severe is from 50% to 100%.

It may start as patchy alopecia areata, then develop into alopecia totalis within 6 months after hair loss was recognized. If you have alopecia universalis, you have hair loss on your whole body.

However, because this is a chronic condition that can occur in cycles, future episodes of hair loss are possible. The causes of alopecia areata are not yet fully understood.

For patients with severe alopecia areata who had meaningful hair regrowth after 1 year of oral baricitinib (Olumiant) therapy, treatment withdrawal resulted in loss of benefit in almost all ...

Hair loss and thinning are common among women of all ages. ... Your skin may feel itchy or painful immediately before the hair falls out. ... If you have hair loss due to alopecia areata, ...

Since alopecia universalis causes such extensive hair loss on the scalp, face, and body, it’s often more challenging to treat than other types of alopecia areata. There’s currently no cure for ...

Ashley Tisdale opens up to PEOPLE in an exclusive interview about how she changed her haircare routine after she was diagnosed with alopecia areata in her mid-20s.